These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15970114)

  • 1. [One more reason to disseminate disease management programs for heart failure in Spain].
    Rodríguez-Artalejo F; Guallar-Castillón P
    Rev Esp Cardiol; 2005 Jun; 58(6):611-4. PubMed ID: 15970114
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management programs for elderly patients with chronic heart failure].
    Pulignano G; Carmenini E; Del Sindaco D; Vlasic J; Tesorio MG; Di Luozzo M; Scherillo M; Giovannini E
    Clin Ter; 2003; 154(3):199-206. PubMed ID: 12910810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure disease management programs: not a class effect.
    Fonarow GC
    Circulation; 2004 Dec; 110(23):3506-8. PubMed ID: 15583088
    [No Abstract]   [Full Text] [Related]  

  • 4. Multidisciplinary heart failure clinics: are they effective in Canada?
    Rich MW
    CMAJ; 2005 Jul; 173(1):53-4. PubMed ID: 15997045
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of the advantages of peritoneal dialysis in the treatment of chronic refractory heart failure].
    Sánchez JE; Rodríguez C; González I; Fernández-Viña A; Núñez M; Peláez B
    Nefrologia; 2010; 30(5):487-9. PubMed ID: 20882088
    [No Abstract]   [Full Text] [Related]  

  • 6. Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial.
    Gregory D; Kimmelstiel C; Perry K; Parikh A; Konstam V; Konstam MA
    Am Heart J; 2006 May; 151(5):1013-8. PubMed ID: 16644325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evidence-based disease management in patients with heart failure (HeartNetCare-HF Würzburg)].
    Störk S; Faller H; Schowalter M; Ertl G; Angermann CE
    Dtsch Med Wochenschr; 2009 Apr; 134(15):773-6. PubMed ID: 19340758
    [No Abstract]   [Full Text] [Related]  

  • 8. TEACH: Trial of Education And Compliance in Heart dysfunction chronic disease and heart failure (HF) as an increasing problem.
    Gwadry-Sridhar F; Guyatt G; O'Brien B; Arnold JM; Walter S; Vingilis E; MacKeigan L
    Contemp Clin Trials; 2008 Nov; 29(6):905-18. PubMed ID: 18703166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health care quality in terminal cardiac decompensation: a "multidisciplinary" reflexion].
    Opasich C; De Feo S; Barbieri M; Majani G
    Ital Heart J Suppl; 2003 Feb; 4(2):112-8. PubMed ID: 12762260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure disease management programs: a cost-effectiveness analysis.
    Chan DC; Heidenreich PA; Weinstein MC; Fonarow GC
    Am Heart J; 2008 Feb; 155(2):332-8. PubMed ID: 18215605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in hospitalization for heart failure in Italy 2001-2003.
    Gigli G; Lispi L; Donati C; Orlandi S; Vallebona A; Gigli L; Reggiardo G
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):367-71. PubMed ID: 19318978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
    Jaarsma T; van der Wal MH; Lesman-Leegte I; Luttik ML; Hogenhuis J; Veeger NJ; Sanderman R; Hoes AW; van Gilst WH; Lok DJ; Dunselman PH; Tijssen JG; Hillege HL; van Veldhuisen DJ;
    Arch Intern Med; 2008 Feb; 168(3):316-24. PubMed ID: 18268174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
    Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the outcomes of heart failure care: putting technology second.
    Havranek EP
    J Am Coll Cardiol; 2005 May; 45(10):1665-6. PubMed ID: 15893184
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of left ventricular lead position on clinical outcomes in the COMPANION study: does placement really matter?
    Freedberg NA
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):769-72. PubMed ID: 19460075
    [No Abstract]   [Full Text] [Related]  

  • 16. Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant.
    Stevenson LW
    Circulation; 2006 Feb; 113(7):1020-7; discussion 1033. PubMed ID: 16490837
    [No Abstract]   [Full Text] [Related]  

  • 17. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counting performance with therapies for heart failure: aiming for quality or quantity?
    Stevenson LW
    Circulation; 2010 Aug; 122(6):561-6. PubMed ID: 20660800
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hospitalizations due to decompensated cardiac insufficiency in Spain].
    Macaya Miguel C; Bover Freire R
    An Med Interna; 2008 Jun; 25(6):253-5. PubMed ID: 19295970
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain natriuretic peptide in heart failure and beyond.
    Mowla MM; Bustami BB
    Saudi Med J; 2006 Oct; 27(10):1457-61. PubMed ID: 17013463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.